Dr Amy Cohn Ophthalmologist

Publications

Selected publications, collaborative study work, reviews and acknowledgements associated with Dr Cohn’s ophthalmology, retina and cataract research.

  1. Guymer, RG, Blair, JPM, De Zanet, S, Apostolopoulos, S, Ciller, C, Wu, Z, for the LEAD Study Group*. Effect of Subthreshold Nanosecond Laser on Loss of OCT Outer Retinal Bands in Age-related Macular Degeneration: A LEAD Study Report. Ophthalmology Science. 5(6);100839. https://doi.org/10.1016/j.xops.2025.100839 Free article
  2. *Cohn AC Member of the LEAD Study Group & co-author
  3. Cohn, AC, Guymer RH. Are Ophthalmologists Ready to Manage Geographic Atrophy? Results from a National Survey. In print. Clinical and Experimental Ophthalmology. December 2025.
  4. Karri, R, Sousa, DC, Hadoux, X, Al-Qureshi, S, Harper, CA, Cohn, AC, et al. Expert Consensus on Fundus Fluorescein Angiography Reporting in Ophthalmology: A Delphi Study. Submitted to British Journal of Ophthalmology, October 2025.
  5. Kumar, H, Bagdasarova, Y, Song, S, Hickey, DG, Cohn, AC et al. Deep Learning-Based Detection of Reticular Pseudodrusen in Age-Related Macular Degeneration on Optical Coherence Tomography. Clin Exp Ophthalmol 2025; Sep. Online ahead of print. DOI: 10.1111/ceo.14607
  6. Wiffen, J, Rogers, S, Hall, AJ, al-Qureshi, SQ, Balatranasingam, C, Cohn, AC et al. Outcomes of Diabetic Macula Oedema in Pregnancy and the Postpartum. IVOS. 66(8)505.
  7. Mehta, H, Gabrielle, PH, Hashimoto, Y, et al. One Year Anti-VEGF Therapy Outcomes in Diabetic Macula Oedema Based on Treatment Intensity: Data from the Fight Retina Blindness! Registry. Ophthalmology Retina. 2025;8(9);872-879. https://doi.org/10.1016/j.oret.2024.04.008 Free article
  8. *Cohn AC Member of the Fight Retinal Blindness! Study Group & co-author
  9. Cohn AC, Guymer, RH. Current Advances in Multimodal Imaging in Geographic Atrophy secondary to Age-related Macular Degeneration: A Review. Invited submission by Taiwan Journal of Ophthalmology. 2024;6;14(4):464-472. DOI: 10.4103/tjo.TJO-D-24-00065 Free article
  10. Goh, KL, Abbott, CJ, Campbell, TG, Cohn, AC, et al. Clinical Performance of Predicting Late Age-Related Macular Degeneration Development Using Multimodal Imaging. Clin Exp Ophthal. 2024;52(7) page 774-782. https://doi.org/10.1111/ceo.14405
  11. Hughes, L, Cohn, AC, Haghighi, N, et al. Orbital Cavernous Venous Malformation Shrinkage During Fractionated Stereotactic Radiotherapy Contributing to Radiation Retinopathy. European Journal of Ophthalmology. 2024;34(5):NP53-NP58.; https://doi.org/10.1177/11206721241259797
  12. Cohn AC, Guymer, RH. Treatments for geographic atrophy are on our doorstep: are we ready? Editorial. Clin Exp Ophthal. 2023; 51(8); 761- 763. https://doi.org/10.1111/ceo.14304
  13. Gabrielle, PH, Nguyen, V, Arnould, L, et al. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry. Ophthalmology Retina. 2022; 6(11);1044-1053. https://doi.org/10.1016/j.oret.2022.05.008 Free article
  14. *Cohn AC Member of the Fight Retinal Blindness! Study Group & co-author
  15. Goh, KL, Abbott, CJ, Clark-Errey, S, Campbell, TG, Cohn, AC et al. Predicting Late Age-Related Macular Degeneration Development: Clinical Performance With Multimodal Imaging and Comparison to a Prediction Model. IVOS ARVO abstract. 2023; 64 (8).
  16. Wu, Z, Chen, FK, Hodgson, LAB, Caruso, E, Harper, CA, Wickremasinghe, SS, Cohn, AC, et al. Observational extension study to the laser intervention in the early stages of age-related macular degeneration (LEAD) clinical trial. Clinical and Experimental Ophthalmology. 2022; 49(8); 831-832. DOI: 10.1016/j.oret.2021.02.015
  17. Cohn AC, Wu Z, Jobling AI, et al. Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration. J. Clin. Med. 2021; 10(3), 484; https://doi.org/10.3390/jcm10030484 Free full text
  18. Cohn AC, Runciman J, Hodgson LAB, et al. Dose response in the subthreshold nanosecond laser trial in the early stages of age-related macular degeneration: a LEAD study report. Ophthalmic Surgery, Lasers and imaging Retina. 2021;52(7):380-386. https://doi.org/10.3928/23258160-20210628-04
  19. Wu, Z, Chen, FK, Hodgson, LAB, et al. Subthreshold Nanosecond Laser in Age-Related Macular Degeneration: Observational Extension Study to the LEAD Clinical Trial. IOVS. 2021; 62(8);1212-1212.
  20. Guymer RH, Chen FK, Hodgson LAB, Caruso, E, Harper, CA, Wickremasinghe, SS, Cohn, AC, et al. Subthreshold Nanosecond Laser in Age-Related Macular Degeneration: Observational Extension Study to the LEAD Clinical Trial. Ophthalmol Retina. 2021; 5(12):1196-1203. https://doi.org/10.1016/j.oret.2021.02.015
  21. Cohn, AC, Wu, Z, Jobling AI, et al. Subthreshold Nano-second Laser Treatment and Age-related Macular Degeneration. Journal of Clinical Medicine. 2021;10(3); 484. https://doi.org/10.3390/jcm10030484 Free full text
  22. Gillies, MC, Nguyen, CL, Nguyen, V, Daien V, Cohn, AC et al. Reply. Fight Retinal Blindness! Study Group. Ophthalmology. 2020; 127(4):e21-e22.
  23. *Cohn AC Member of the Fight Retinal Blindness! Study Group & co-author
  24. Nguyen, CL, Gillies, MC, Nguyen, V, Daien, V, Cohn AC, et al. Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents. Ophthalmology. 2019; 126(5)735-742. DOI: 10.1016/j.ophtha.2018.11.036
  25. Wu, Z, Luu, CD, Hodgson, LAB, Cohn AC (22nd author listed) et al. Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomised Trial in Age-Related Macular Degeneration: A LEAD Study Report. Ophthalmol Retina. 2019; 3(12):1026-1034. DOI: 10.1016/j.oret.2019.07.008
  26. Teo, KYC, Squirrell, DM, Nguyen, V, Banerjee, G, Cohn, AC et al. A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculaopthy: Fight Retina Blindness! Cohort. Ophthal Retina Mar 2019; 3(3): 220-229. DOI: 10.1016/j.oret.2018.11.003
  27. Guymer RH, Wu Z, Hodgson LAB, et al: Sub-threshold nanosecond laser intervention in Age-related macular degeneration: the LEAD Randomized Control Clinical Trial. Ophthalmology 2019 126(6):829-838. DOI: 10.1016/j.ophtha.2018.09.015
  28. *Cohn AC Member of the LEAD Study Group & co-author
  29. Daien, V, Nguyen V, Essex, RW, Morlet, N, Barthelmes, D, Gillies, MC, Hunt, A, Essex, R, Dayajeewa, C, Hunyor, A, Fraser-Bell, S, Younan, C, Fung, A, Guymer, R, Louis, D, Arnold, JJ, Chan, D, Harper, CA, O’Day, J, Daniell, M, Field, A, Chow, LP, Barthelmes, D, Cohn, AC et al. Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration. Ophthalmology. 2018; 125(1):66-74. DOI: 10.1016/j.ophtha.2017.07.005
  30. Daien, V, Nguyen, V, Morlet, N et al. Outcomes and predictive factors after cataract surgery in patients with neovascular age-related macular degeneration. The Fight Retinal Blindness! Project. American Journal of Ophthalmology. 2018;190;50-57. DOI: 10.1016/j.ajo.2018.03.012
  31. *Cohn AC Member of the Fight Retinal Blindness! Study Group & co-author
  32. Lek JJ, Brassington KH, Luu CD, et al. Subthreshold nano-second laser intervention in intermediate age-relate macula degeneration. Study Design and Baseline characteristics of the Laser in Early stages of Age-Related Macula Degeneration (LEAD) study. Ophthalmol Retina 2017; 1(3); 227- 239.
  33. *Cohn AC Member of the LEAD Study Group & co-author
  34. Cohn AC, Busija L, Robman LD, et al Younger Siblings, C-reactive Protein and Risk of Age-related Macular Degeneration. Am J of Epidemiology 2013;177(9): 933-943. DOI: 10.1093/aje/kws332
  35. Cohn AC, Turnbull C, Ruddle JB et al. Best macular dystrophy in Australia: phenotypic profile and identification of novel BEST1 mutations. Eye 2011; 25: 208-217.
  36. Van Bergen NJ, Crowston JG, Kearns, JS, Staffieri, SE, Cohn AC et al Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy. PLoS One; 2011;6(6):e21347. DOI: 10.1371/journal.pone.0021347 Free full text
  37. Kearns LS, Forrest M, Cohn AC et al Does acute loss of vision in Autosomal Dominant Optic Atrophy occur in early childhood? Ophthal Genet; 2010; 31(1): 44-6. DOI: 10.3109/13816810903479842
  38. Kearns, ML, Cohn, AC, Osborne, EC, et al. Bench to Bedside: Translating Genetic Eye Research into Different Reproductive Options. Clinical and Experimental Ophthalmology. 2008; 36 (A760).
  39. Cohn AC, Toomes C, Hewitt AW et al The Natural History of OPA1-related Autosomal Dominant Optic Atrophy. BJO; 2008; 92(10): 1333-1336. DOI: 10.1136/bjo.2007.134726
  40. Cohn AC, Toomes C, Potter, C, et al. Autosomal Dominant Optic Atrophy: Penetrance and Expressivity in Patients with OPA1 Mutations. AJO April 2007; 143(4) 565-662. DOI: 10.1016/j.ajo.2006.12.038
  41. Cohn, AC, Wong, EYH, Kowal, L. Multi-positional MRI Imaging to Assist the Understanding of Complex Strabismus Cases. Clinical and Experimental Ophthalmology. 2007; 35; A89.
  42. Craig, JE, Hewitt, AW, Dimassi DP, Howell, N, Toomes, C, Cohn AC, et al. The role of the Met98Lys optineurin variant in inherited optic nerve diseases. BJO 2006; 90 (11); 1420-1424. DOI: 10.1136/bjo.2006.099333
  43. Hewitt, AW, Bennett, SL, Cohn, AC, et al. Are Glaucomatous Disc Changes Evident Prior to Diagnosis of Glaucoma? Clinical and Experimental Ophthalmology. 2005; 33; A23.
  44. Bennett, SL, Mackey, DA, Hewitt, AW, Kearns, LS, Cohn, AC, et al. Are Glaucomatous Disc Changes Evident Prior to Diagnosis of Glaucoma in Myocillin Pedigrees? IOVS. 46(13);33-33.
  45. McKay, JD, Patterson, B, Craig, JE, Russell-Eggitt, IM, Wirth, MG, Burdon, KP, Hewitt, AW, Cohn, AC et al. The telomere of human chromosome 1p contains at least two independent congenital cataract predisposition genes. 2005; BJO 89(7):831-834. DOI: 10.1136/bjo.2004.058495
  46. Cohn, AC, Kotschet, K, Veitch, A, et al. Novel Opthalmological Features in Hereditary Endotheliopathy with Retinopathy, Nephropathy, and Stroke Syndrome. Clinical and Exp Ophthal. 2005; 33 (2):181-183. DOI: 10.1111/j.1442-9071.2005.00976
  47. Cohn AC, Kearns LS, Savarirayan R, et al. Chromosomal Abnormalities and Glaucoma: A Case of Congenital Glaucoma with Trisomy 8q22-qter/Monosomy 9p23-pter. Ophthal Genet. 2005; 26 (1):45-53. DOI: 10.1080/13816810590918398
  48. Cohn, AC, Craig, JE, Mackey, et al. Variable Penetrance and Expressivity of Autosomal Dominant Optic Atrophy. IOVS. 2004; 45(13); 3721-3721.
  49. Cohn, AC, Toomes, C, Ingelhearn, C, et al. Autosomal Dominant Optic Atrophy: variable Penetrance and Expressivity and Associations with Normal Tension Glaucoma. Clinical and Experimental Ophthalmology. 2004. 32(A2).
  50. Cohn AC, Wilson WM, Yan B, et al. An Analysis of Clinical Outcomes Following In-Hospital Adult Cardiac Arrest. Internal Medicine Journal. 34(7): 398-402, 2004. DOI: 10.1111/j.1445-5994.2004.00566.x

Acknowledgements in publications

Nguyen V, Vaze A, Fraser-Bell, S et al. Outcomes of suspending VEGF inhibitors for neovascular Age-related Macular Degeneration with lesions have been inactive for 3 months. Ophthalmology Retina. 2019; 3(8):623-628. DOI: 10.1016/j.oret.2019.05.013